Vernonia amygdalina Delile Induces Apoptotic Effects of PC3 Cells: Implication in the Prevention of Prostate Cancer

Clement G Yedjou*; William Johnson; Solange S Tchounwou; Shaloam Dasari; Sylvianne Njiki; Paul B Tchounwou

**Clement G Yedjou*, William Johnson, Solange S Tchounwou, Shaloam Dasari, Sylvianne Njiki and Paul B Tchounwou**

Volume3-Issue9
Dates: Received: 2022-09-07 | Accepted: 2022-09-28 | Published: 2022-09-30
Pages: 1118-1124

Abstract

Background: Prostate Cancer (PCa) is one of the common cancers in males and its incidence keeps increasing globally. Approximately 81% of PCa is diagnosed during the early stage of the disease. The treatment options for prostate care include surgery, radiotherapy, and chemotherapy, but these treatments often have side effects that may lead to issues such as impotence or decreased bowel function. Our central goal is to test the apoptotic effects of Vernonia amygdalina Delile (an edible medicinal plant that is relatively inexpensive, nontoxic, and virtually without side effects) for the prevention of PCa using human adenocarcinoma (PC-3) cells as a test model.

Methods: To address our central goal, PC-3 cells were treated with Vernonia amygdalina Delile (VAD). Cell cycle arrest and cell apoptosis were evaluated by Flow Cytometry assessment. Nucleosomal DNA fragmentation was detected by agarose gel electrophoresis.

Results: Flow cytometry data showed that VAD induced cell cycle arrest at the G0/G1 checkpoint and significantly upregulated caspase-3 in treated cells compared to the control cells. Agarose gel electrophoresis resulted in the formation of DNA ladders in VAD-treated cells.

Conclusion: These results suggest that inhibition of cancer cell growth, induction of cell cycle arrest, and apoptosis through caspase-3 activation and nucleosomal DNA fragmentation are involved in the therapeutic mechanisms of VAD as a candidate drug towards the prevention and/or treatment of PCa.

FullText HTML FullText PDF DOI: 10.37871/jbres1564

Certificate of Publication

Copyright

How to cite this article

Yedjou CG, Johnson W, Tchounwou SS, Dasari S, Njiki S, Tchounwou PB. Vernonia amygdalina Delile Induces Apoptotic Effects of PC3 Cells: Implication in the Prevention of Prostate Cancer. J Biomed Res Environ Sci. 2022 Sep 30; 3(9): 1118-1124. doi: 10.37871/jbres1564, Article ID: JBRES1564, Available at: https://www.jelsciences.com/articles/jbres1564.pdf

Subject area(s)

Oncology

Cancer

Urology

References

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. TL - 60. CA Cancer J Clin. 2010. doi:10.3322/caac.20073
Howlader N, Noone AM, Krapcho M, et al. National Cancer Institute SEER Cancer Statistics Review 1975-2012. Natl Cancer Inst. 2015. doi: 10.1103/PhysRevA.69.053616
Siegel R, Miller K, Jemal A. Cancer statistics, 2015 . CA Cancer J Clin. 2015;65(1):29. doi:10.3322/caac.21254.
Ferraldeschi R, Pezaro C, Karavasilis V, de Bono J. Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer. Annu Rev Med. 2013;64(1):1-13. doi: 10.1146/annurev-med-121211-091605
Roudier MP, True LD, Higano CS, et al. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol. 2003. doi: 10.1109/INNOVATIONS.2011.5893843
Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012. doi: 10.3322/caac.21149
Syed DN, Khan N, Afaq F, Mukhtar H. Chemoprevention of prostate cancer through dietary agents: Progress and promise. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2193-2203. doi: 10.1158/1055-9965.EPI-06-0942
Yedjou C, Izevbigie E, Tchounwou P. Preclinical assessment of Vernonia amygdalina leaf extracts as DNA damaging anti-cancer agent in the management of breast cancer. In: International Journal of Environmental Research and Public Health. 2008;5:337-341. doi: 10.3390/ijerph5050337
Johnson W, Tchounwou PB, Yedjou CG. Therapeutic mechanisms of vernonia amygdalina delile in the treatment of prostate cancer. Molecules. 2017;22(10). doi: 10.3390/molecules22101594
Oyedeji KO, Bolarinwa AF, Akintola AM. Effect Of Methanolic Extract of Vernonia Amygdalina on Haematological and Plasma Biochemical Parameters in Male Albino Rats. J Dent Med Sci. 2013.
Yedjou CG. Vernonia amygdalina—Induced Growth Arrest and Apoptosis of Breast Cancer (MCF-7) Cells. Pharmacol Pharm. 2013. doi: 10.4236/pp.2013.41013
Clement G. Yedjou SSTKW& PBT. Novel Cellular Staining Protocol And Antiproliferative Effect Of Vernonia Amygdalina Delile On Lung And Prostate Cancer Cells. August 2018. doi: 10.5281/ZENODO.1403369
Yedjou CG, Tchounwou HM, Tchounwou PB. DNA damage, cell cycle arrest, and apoptosis induction caused by lead in human leukemia cells. Int J Environ Res Public Health. 2015;13(1). doi: 10.3390/ijerph13010056
Yedjou C, Tchounwou P, Jenkins J, McMurray R. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. J Hematol Oncol. 2010. doi: 10.1186/1756-8722-3-28
Ioannou YA, Chen FW. Quantitation of DNA fragmentation in apoptosis. Nucleic Acids Res. 1996. doi: 10.1093/nar/24.5.992
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917. doi: 10.1002/ijc.25516
Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000;92(19):1582-1592.
Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000;283(3):354-360. doi: 10.1001/jama.283.3.354
Mann J. Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer. 2002;2(February):143. doi: 10.1038/nrc723
Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007. doi: 10.1021/np068054v
Singh S, Sharma B, Kanwar SS, Kumar A. Lead Phytochemicals for Anticancer Drug Development. Front Plant Sci. 2016. doi: 10.3389/fpls.2016.01667
Bachrach Z. Contribution of Selected Medicinal Plants for Cancer Prevention and Therapy. Acta Fac Medicae Naissensis. 2012. doi: 10.2478/v10283-012-0016-4
Efferth T, Koch E. Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy. Curr Drug Targets. 2011. doi: 10.2174/138945011793591626
Zacchino SA, Butassi E, Cordisco E, Svetaz LA. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms. Phytomedicine. 2017.
Gonzalez-Polo R-A. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci. 2005. doi: 10.1242/jcs.02447
Edinger AL, Thompson CB. Death by design: Apoptosis, necrosis and autophagy. Curr Opin Cell Biol. 2004. doi: 10.1016/j.ceb.2004.09.011
Amin ARMR, Karpowicz PA, Carey TE, et al. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Semin Cancer Biol. 2015;35:S55-S77. doi: 10.1016/j.semcancer.2015.02.005
Mantena SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther. 2006;5(2):296-308. doi: 10.1158/1535-7163.MCT-05-0448
LU W, DU S, WANG J. Berberine inhibits the proliferation of prostate cancer cells and induces G0/G1 or G2/M phase arrest at different concentrations. Mol Med Rep. 2015;11(5):3920-3924. doi: 10.3892/mmr.2014.3139
Gupta S, Afaq F, Mukhtar H. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun. 2001;287(4):914-920. doi: 10.1006/bbrc.2001.5672
Shukla S, Gupta S. Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther. 2006;5(4):843-852. doi: 10.1158/1535-7163.MCT-05-0370
Shukla S, Gupta S. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle. 2007;6(9):1102-1114. doi: 10.4161/cc.6.9.4146
Fulda S. Modulation of apoptosis by natural products for cancer therapy. Planta Med. 2010. doi: 10.1055/s-0030-1249961
Bailly C. Ready for a comeback of natural products in oncology. Biochem Pharmacol. 2009. doi: 10.1016/j.bcp.2008.12.013
Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release : its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis. 2002. doi: 10.1093/carcin/23.1.143
Lou S, Wang Y, Yu Z, Guan K, Kan Q. Curcumin induces apoptosis and inhibits proliferation in infantile hemangioma endothelial cells via downregulation of MCL-1 and HIF-1α. Med (United States). 2018. doi: 10.1097/MD.0000000000009562
Wong RSY. Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 2011. doi: 10.1186/1756-9966-30-87
Yeung MC. Accelerated apoptotic DNA laddering protocol. Biotechniques. 2002.
Yedjou CG, Tchounwou PB. In vitro assessment of oxidative stress and apoptotic mechanisms of garlic extract in the treatment of acute promyelocytic leukemia. J Cancer Sci Ther. 2012;2012(Suppl 3):6. doi: 10.4172/1948-5956.S3-006
Izevbigie EB. Discovery of water-soluble anticancer agents (edotides) from a vegetable found in Benin City, Nigeria. Exp Biol Med (Maywood). 2003;228(3):293-298. doi: 1535-3702/03/2283-0293
Chen Z, Sun X, Shen S, et al. Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation. J Biol Chem. 2013. doi: 10.1074/jbc.M112.442970
Millimouno FM, Dong J, Yang L, Li J, Li X. Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature. Cancer Prev Res. 2014. doi: 10.1158/1940-6207.CAPR-14-0136
Aung TN, Qu Z, Kortschak RD, Adelson DL. Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. Int J Mol Sci. 2017. doi: 10.3390/ijms18030656